Cite Filings / RLAY / 0000950170-25-057333
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

Relay Therapeutics, Inc. · Filed 2025-04-23 · Acc 0000950170-25-057333

Documents 1

  • DEF 14A Proxy Statement , rlay-20250423.htm

Around this filing

  • 2026-04-28 DEF 14A Proxy Statement
  • 2025-04-28 144 Sale of Securities
  • 2025-04-24 4 President and CEO sold 61,422 shares at $2.97 ($182,423)
  • 2025-04-23 ARS Annual Report to Security Holders
  • 2025-04-23 DEFA14A Proxy Materials
  • 2025-04-23 DEF 14A Proxy Statement
  • 2024-04-23 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading rlay-20250423.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…